Drug details

Egrifta SV (tesamorelin for injection)

type of Growth Hormone Releasing Factors

Egrifta SV (tesamorelin kit) is a growth hormone releasing factor (GHRF) analog used to reduce excess abdominal fat in HIV-infected adult patients with lipodystrophy.

The drug is often used to treat HIV .

The following drugs are related to Egrifta SV, either as a replacement or used together:

• Ziagen (abacavir sulfate)
• Videx EC (didanosine delayed-release capsules)
• Videx (didanosine pediatric powder for oral solution)
• Emtriva (emtricitabine)
• Epivir (lamivudine)
• Epivir-HBV (lamivudine tablets and oral solution)
• Skytrofa (lonapegsomatropin-tcgd for injection)
• Ngenla (somatrogon-ghla injection)
• Retrovir (zidovudine)
• Retrovir IV (zidovudine injection)
• Zerit (stavudine)
• Vemlidy Tablets (tenofovir alafenamide)
• Viread (tenofovir disoproxil fumarate)